Paragonix Technologies aims to boost survival of donated lungs

Many lungs being transported for transplant arrive in such bad shape that they cannot be used. Paragonix Technologies aims to change that with SherpaLung, a specialized cooler that keeps lungs properly inflated and at the right temperature to survive an airplane trip.

Paragonix Technologies just landed support from the Lung Transplant Foundation to continue developing and commercializing SherpaLung, the latest in its series of specialized organ transport carriers. Braintree, Mass.–based Paragonix launched similar devices for hearts and kidneys within the past several months, according to CEO Bill Edelman.

SherpaLung is not yet approved for sale in the U.S. Paragonix has patents issued and pending for the device.

Based on the current method of lung preservation and transportation, only one out of every five lungs donated in the United States can be used for transplantation, according to the Organ Procurement and Transplantation Network. SherpaLung also provides organ parameter monitoring during storage and transport of donor lungs to recipients for implantation. Lung transplantation is considered gold standard therapy for patients in end-stage pulmonary failure due to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. 

“The lung transplant field is in critical need of easy-to-use and effective preservation devices for the transport of lungs between organ donation and implantation,” said Lung Transplant Foundation president Jeff Goldstein. “The Paragonix approach to organ preservation is innovative and finally addresses the clinical needs for donor lung transportation. We are so incredibly excited about partnering with Paragonix Technologies to support these efforts.”

The parties did not make public the amount provided by the foundation.

“They decided that they believe the need is so profound and they’re impressed with our technology and our other initiatives in organ transplantation,” Edelman said.

SherpaLung is a single-use, continuous monitoring and validated temperature control product similar in design to Paragonix’s SherpaPak cardiac and kidney transport system.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW